| scholarly article | Q13442814 |
| P50 | author | Stephen P. Fortmann | Q69504200 |
| P2093 | author name string | Kristen M J Azar | |
| Latha P Palaniappan | |||
| Katherine G Hastings | |||
| Jia Pu | |||
| Beinan Zhao | |||
| Vani Nimbal | |||
| Robert Romanelli | |||
| P2860 | cites work | Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association | Q26996098 |
| A systematic review of physical activity interventions in Hispanic adults. | Q27693333 | ||
| Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report | Q27861020 | ||
| Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics | Q28179830 | ||
| Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association | Q28235865 | ||
| 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Q28301815 | ||
| Heart disease and stroke statistics--2011 update: a report from the American Heart Association | Q29547236 | ||
| General cardiovascular risk profile for use in primary care: the Framingham Heart Study | Q29614189 | ||
| Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | Q29619842 | ||
| Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial | Q29622926 | ||
| Randomized controlled trial lifestyle interventions for Asian Americans: a systematic review. | Q30587192 | ||
| Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia | Q33604888 | ||
| Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants | Q33776950 | ||
| Is there progress toward eliminating racial/ethnic disparities in the leading causes of death? | Q34077260 | ||
| Statin-associated myopathy | Q34187996 | ||
| Problems with the collection and interpretation of Asian-American health data: omission, aggregation, and extrapolation | Q34280673 | ||
| Racial/ethnic differences in dyslipidemia patterns | Q34382652 | ||
| Cardiovascular risk factors among Asian Americans | Q34404197 | ||
| Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study | Q34490730 | ||
| Food insecurity is associated with acculturation and social networks in Puerto Rican households | Q34504546 | ||
| Coronary heart disease in south Asians overseas: a review | Q34505788 | ||
| Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment | Q34561428 | ||
| Statin safety: a systematic review | Q34566154 | ||
| Safety and efficacy of statins in Asians | Q34574500 | ||
| Cardiovascular disease mortality in Asian Americans | Q34762170 | ||
| Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales | Q35178925 | ||
| Effects of extended-release niacin with laropiprant in high-risk patients | Q35205560 | ||
| Diabetes, insulin resistance and vascular disease among Indian Asians and Europeans | Q36285251 | ||
| Is South Asian ethnicity an independent cardiovascular risk factor? | Q36415344 | ||
| 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Q36429024 | ||
| Acculturation and healthy lifestyle among Latinos with diabetes | Q36495423 | ||
| Call to action: cardiovascular disease in Asian Americans: a science advisory from the American Heart Association | Q36498650 | ||
| Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. | Q36738148 | ||
| Interventions for improving nutrition and physical activity behaviors in adult African American populations: a systematic review, January 2000 through December 2011 | Q36950225 | ||
| Cardiovascular risk factors among Asian Americans: results from a National Health Survey | Q36998825 | ||
| SLCO1B1 Polymorphisms and Statin-Induced Myopathy | Q37410969 | ||
| A prospective study of statin use and mortality among 67,385 blacks and whites in the Southeastern United States | Q37412469 | ||
| Transporter pharmacogenetics and statin toxicity | Q37627544 | ||
| Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial | Q38462845 | ||
| Application of new cholesterol guidelines to a population-based sample | Q39227879 | ||
| Statin myopathy: a lipid clinic experience on the tolerability of statin rechallenge | Q39711727 | ||
| Dietary carbohydrates, glycemic load and serum high-density lipoprotein cholesterol concentrations among South Indian adults | Q39820397 | ||
| Heart disease prevention among Chinese immigrants | Q40166450 | ||
| Acculturation and coronary heart disease in Japanese-Americans | Q41060514 | ||
| Efficacy and safety of simvastatin in Asian and non-Asian coronary heart disease patients: a comparison of the GOALLS and STATT studies. | Q42634114 | ||
| ACC/AHA/NHLBI clinical advisory on the use and safety of statins | Q44079578 | ||
| Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study | Q44157589 | ||
| Sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effects in 51,321 Japanese hypercholesterolemic patients | Q44374640 | ||
| Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America | Q44516848 | ||
| Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study. | Q44588871 | ||
| Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium | Q44828075 | ||
| Acculturation and health risk behaviors among Californians of Korean descent | Q44945199 | ||
| Health behaviors of adults: United States, 2008-2010. | Q45803894 | ||
| ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin. | Q45993642 | ||
| Variation in nutrient intakes by ethnicity: results from the Study of Women's Health Across the Nation (SWAN). | Q46021403 | ||
| Statin effects on LDL and HDL cholesterol in South Asian and white populations. | Q46034432 | ||
| Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART Study | Q46161143 | ||
| Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: prevalence of coronary and hypertensive heart disease and associated risk factors | Q46560134 | ||
| 75 years of mortality in the United States, 1935-2010. | Q46575996 | ||
| Ethnic variations in lipid-lowering in response to a statin (EVIREST): a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). | Q46576533 | ||
| Coronary heart disease mortality for six ethnic groups in California, 1990-2000. | Q46960233 | ||
| Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006. | Q47336401 | ||
| Dietary Patterns of Hispanic Elders Are Associated with Acculturation and Obesity | Q47370255 | ||
| Meeting of the International Working Group on Coronary Artery Disease in South Asians. 24 March 1996, Orlando, Florida, USA. | Q50969390 | ||
| Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males | Q57500331 | ||
| Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE) | Q73840956 | ||
| Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial | Q79165142 | ||
| 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Q86757444 | ||
| Hypertension, abnormal cholesterol, and high body mass index among non-Hispanic Asian adults: United States, 2011-2012 | Q95515813 | ||
| P433 | issue | 1 | |
| P921 | main subject | dyslipidemias | Q66291209 |
| P304 | page(s) | 205-216 | |
| P577 | publication date | 2016-03-01 | |
| P1433 | published in | Endocrinology and Metabolism Clinics of North America | Q15763298 |
| P1476 | title | Dyslipidemia in Special Ethnic Populations | |
| P478 | volume | 45 |
| Q91772474 | Atherosclerotic Cardiovascular Disease Risk Prediction in Disaggregated Asian and Hispanic Subgroups Using Electronic Health Records |
| Q39244211 | The associations between early pregnancy lipid profiles and pregnancy outcomes |
| Q64071119 | Years of Potential Life Lost Because of Cardiovascular Disease in Asian-American Subgroups, 2003-2012 |
Search more.